Intralesional Verapamil is a commonly used treatment option for Peyronie's disease. Concern exists as regards its relative invasiveness and patients' compliance. Preliminary experience suggests that penile extenders may be effective in reducing penile curvature. Aim of the current study was to compare the efficacy and tolerability of the penile extender Andropenis® with intralesional Verapamil. An oral combination of paraminobenzoate and antioxidants (PeironiMEV ®), suggested to be active on the plaque, was added to the penile stretcher arm.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Urology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2011 Elsevier Inc. Published by Elsevier Inc. All rights reserved.